Company intelligence / Profile preview

Beijing SJAR

Beijing, Beijing, China

Ownership: Private
Development stage: Other

Overview

Beijing SJAR is a specialized healthcare and biotechnology company focused on regenerative medicine and medical aesthetics. The company integrates clinical services with advanced research in stem cell technology and autologous fat transplantation to provide anti-aging and reconstructive solutions. Operating primarily through its flagship medical beauty hospital and dedicated biotech research arm, Beijing SJAR develops proprietary cell-based therapies aimed at tissue repair and skin rejuvenation. The organization is recognized for its expertise in facial contouring and regenerative aesthetic procedures within the Chinese market.

Therapeutic areas: DermatologyOther
Modalities: Cell therapyStem cell therapy
Industry: Biotech

Beyond the preview

Go deeper on Beijing SJAR.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Beijing SJAR.

Explore the full profile